GENELUX-Final-Logo-Notagline.png
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
24 mai 2024 08h00 HE | Genelux Corporation
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
GENELUX-Final-Logo-Notagline.png
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
09 mai 2024 16h25 HE | Genelux Corporation
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
GENELUX-Final-Logo-Notagline.png
Genelux Corporation Announces New Chief Financial Officer
28 août 2023 07h00 HE | Genelux Corporation
WESTLAKE VILLAGE, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Lourie S. Zak will join the...
GENELUX-Final-Logo-Notagline.png
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
20 juil. 2023 16h45 HE | Genelux Corporation
WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced two key management promotions, as well...
GENELUX-Final-Logo-Notagline.png
Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023
22 juin 2023 07h00 HE | Genelux Corporation
WESTLAKE VILLAGE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that it will be added to the...
MJNA_Logo.png
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
26 juil. 2022 09h00 HE | Medical Marijuana, Inc.
SAN DIEGO, CA, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that...